Xamoterol
Systematic (IUPAC) name | |
---|---|
(RS)-N-(2-{[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino}ethyl)morpholine-4-carboxamide | |
Identifiers | |
CAS Number | 81801-12-9 |
ATC code | C01CX07 (WHO) |
PubChem | CID 155774 |
IUPHAR/BPS | 538 |
ChemSpider | 137213 |
UNII | 7HE0JQL703 |
KEGG | D06328 |
ChEMBL | CHEMBL75753 |
Chemical data | |
Formula | C16H25N3O5 |
Molar mass | 339.387 g/mol |
| |
| |
(what is this?) (verify) |
Xamoterol is a cardiac stimulant. It works by binding to the β1 adrenergic receptor. It is a 3rd generation adrenergic β receptor partial agonist.[1] It provides cardiac stimulation at rest but it acts as a blocker during exercise.[2]
References
- ↑ Marlow, HF (1989). "Xamoterol, a β1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure" (PDF). British Journal of Clinical Pharmacology. 28 Suppl 1: 23S–30S. PMID 2572251. Retrieved 6 March 2016.
- ↑ Rang, H.P.; Dale, M.M.; Ritter, J.M.; Moore, P.K. (1999). Pharmacology (5th ed.). Edinburgh; New York: Churchill Livingstone. p. 163. ISBN 0443059748.
|
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.